BRAF and melanoma: Afterwards, as result of genome sequencing and identification of the main mutation, a series of therapeutic agents have been discovered; about half of all melanomas have mutations in the BRAF (v-raf murine sarcoma viral oncogene homolog B1) gene [8,9].